Alzheimer's disease biomarker discovery using in silico literature mining and clinical validation
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Background: Alzheimer’s Disease (AD) is the most widespread form of dementia in the elderly but despite progress made in recent years towards a mechanistic understanding, there is still an urgent need for disease modification therapy and for early diagnostic tests. Substantial international efforts are being made to discover and validate biomarkers for AD using candidate analytes and various data-driven 'omics' approaches. Cerebrospinal fluid is in many ways the tissue of choice for biomarkers of brain disease but is limited by patient and clinician acceptability, and increasing attention is being paid to the search for blood-based biomarkers. The aim of this study was to use a novel in silico approach to discover a set of candidate biomarkers for AD. Methods: We used an in silico literature mining approach to identify potential biomarkers by creating a summarized set of assertional metadata derived from relevant legacy information. We then assessed the validity of this approach using direct assays of the identified biomarkers in plasma by immunodetection methods. Results: Using this in silico approach, we identified 25 biomarker candidates, at least three of which have subsequently been reported to be altered in blood or CSF from AD patients. Two further candidate biomarkers, indicated from the in silico approach, were choline acetyltransferase and urokinase-type plasminogen activator receptor. Using immunodetection, we showed that, in a large sample set, these markers are either altered in disease or correlate with MRI markers of atrophy. Conclusions: These data support as a proof of concept the use of data mining and in silico analyses to derive valid biomarker candidates for AD and, by extension, for other disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326 · cited 1×
“Other promising candidates suggested by textual analysis, and where there is published data suggesting that these proteins are altered either in blood or CSF, include CRP [17-19], Complement factor 1 [20,21], butyrylcholinesterase [22] and BACE1 [23,24].”
BackgroundSelf-citationCerebrospinal fluid and plasma biomarkers in Alzheimer disease
Blennow, K., Hampel, H., Weiner, M., & Zetterberg, H. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.4 · Cited by 1,863 · cited 1×
“The most widely used strategy for the discovery of biomarkers is predicated on the identification of potential candidate biomarkers using knowledge of disease processes followed by validation, comparing healthy control to affected subjects [3].”
BackgroundThambisetty, M., Simmons, A., Velayudhan, L., Hye, A., Campbell, J., Zhang, Y., Wahlund, L.-O., Westman, E., Kinsey, A., Güntert, A., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.78 · Cited by 405
Self-citationBlood-Based Biomarkers of Alzheimer's Disease: Challenging but Feasible
Thambisetty, M., & Lovestone, S. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.09.84 · Cited by 182
Self-citationFourches, D., Barnes, J. C., Day, N. C., Bradley, P., Reed, J. Z., & Tropsha, A. (2010) · Chemical Research in Toxicology · doi:10.1021/tx900326k · Cited by 162 · cited 1×
“com/tag/sofia/ and [10]) and was powered by the broad vocabularies around Proteins, Observations and Tissues, to enable semantic consistency of all final assertions.”
BackgroundSelf-citationEwers, M., Zhong, Z., Bürger, K., Wallin, A., Blennow, K., Teipel, S. J., Shen, Y., & Hampel, H. (2008) · Brain · doi:10.1093/brain/awn034 · Cited by 119
Cited by
An analysis of the use of animal models in predicting human toxicology and drug safety
Bailey, J., Thew, M., & Balls, M. (2014) · Alternatives to Laboratory Animals · doi:10.1177/026119291404200306 · Cited by 182
Banik, A., Brown, R. E., Bamburg, J., Lahiri, D. K., Khurana, D., Friedland, R. P., Chen, W., Ding, Y., Mudher, A., Padjen, A. L., et al. (2015) · Journal of Alzheimer’s Disease · doi:10.3233/jad-150136 · Cited by 102
Advancing Alzheimer’s research: a review of big data promises
Zhang, R., Simon, G., & Yu, F. (2017) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2017.07.002 · Cited by 77
“The second study discovered 25 candidate AD biomarkers from diverse resources, including MEDLINE, AD research forums and related gene and disease databases (55).”
BackgroundAn analysis of the use of dogs in predicting human toxicology and drug safety
Bailey, J., Thew, M., & Balls, M. (2013) · Alternatives to Laboratory Animals · doi:10.1177/026119291304100504 · Cited by 71
Garcia, G., Fernandes, A., Stein, F., & Brites, D. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.833066 · Cited by 32
“, 2016), also indicated as an AD biomarker involved in the regulation of BACE1-mediated APP processing (Xie and Guo, 2005; Greco et al., 2012).”
Background
Metadata
- Authors
- Greco, I., Day, N., Riddoch-Contreras, J., Reed, J., Soininen, H., Kłoszewska, I., Tsolaki, M., Vellas, B., Spenger, C., Mecocci, P., Wahlund, L.-O., Simmons, A., Barnes, J., & Lovestone, S.
- Venue
- Journal of Translational Medicine
- Published
- 2012-10-31
- Volume
- 10
- Issue
- 1
- Pages
- 217-217
- ISSN
- 1479-5876 (ISSN-L)
- OpenAlex
- W2103331057
- Cited by
- 31
- References
- 6
- FWCI
- 1.84
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Alzheimer's disease biomarker discovery using in silico literature mining and clinical validation. https://app.cochat.ai/papers/10.1186/1479-5876-10-217
- The paper
- Greco, I., Day, N., Riddoch-Contreras, J., Reed, J., Soininen, H., Kłoszewska, I., Tsolaki, M., Vellas, B., Spenger, C., Mecocci, P., Wahlund, L.-O., Simmons, A., Barnes, J., & Lovestone, S. (2012). Alzheimer's disease biomarker discovery using in silico literature mining and clinical validation. Journal of Translational Medicine. https://doi.org/10.1186/1479-5876-10-217
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.